Porcine Reproductive and Respiratory Syndrome

XI'AN, China, Dec. 15, 2023 /PRNewswire/ -- It was recently announced that Tianlong Technology complies with the requirements of Chinese Good Manufacturing Practices for animal drugs. This approval further ensures Tianlong's focus on standardized workflows in the development of animal products. Continue Reading Tianlong Solution for Livestock Disease Detection Over the last 26 years, Tianlong Technology has been committed to delivering all-encompassing solutions for molecular diagnostics and genetic testing. In the field of livestock husbandry, Tianlong provides pioneering disease detection solutions, comprising a variety of instruments and matching reagents that allow for swift and reliable detection of swine fever, African swine fever, porcine reproductive and respiratory syndrome, porcine viral diarrhea, foot-and-mouth disease, and avian influenza, among others. Tianlong's livestock disease detection solution comprises a range of instruments including GeneRotex 96 Nucleic Acid Extractor, Libex Nucleic Acid Extractor, Gentier 96E/96R Real-Time PCR System, and Gentier Mini Series Portable Real-Time PCR System. These instruments exhibit outstanding performance in pathogene nucleic acid detection, guaranteeing the ability to quickly obtain precise, stable, and reliable outcomes, which enhances detection efficiency significantly. Multiple throughput can also meet various detection quantity requirements. Alongside instruments, Tianlong's compatible nucleic acid extraction and PCR detection kits have also played a crucial part in detecting livestock diseases in many countries. In Southeast Asia, Tianlong partnered with top agribusiness and food groups to undertake livestock disease detection. The process involved the use of Tianlong's Animal Virus DNA and RNA Extraction Kit, and African Swine Fever Virus (ASFV) Nucleic Acid Detection Kit (Fluorescence PCR Method). Both kits demonstrate exceptional performance in a wider range of sample types and higher sensitivity. When used in conjunction with Tianlong's instruments, it has capacity to detect large sample volume hence increase the detection rate of low concentration samples. In China, Tianlong's avian influenza detection products have been utilized effectively by Centers for Disease Control and Prevention (CDCs), animal epidemic control agencies, and medical institutions during numerous avian influenza epidemics. Furthermore, Tianlong's Avian Influenza Virus H7N9 Nucleic Acid Detection Kit (Fluorescence PCR Method), which includes the detection of both LPAI and HPAI, has gained attention in an animal disease testing laboratory in the Philippines due to its exceptional performance. To ensure adherence to strict quality standards, Tianlong has implemented a comprehensive quality management system. With ISO 13485 and ISO 9001 certifications, alongside standardized GMP product line for animal drugs, the company's focus on standardized workflows ensures the production of top-quality products. At present, Tianlong's products have been extensively used in more than 100 countries and regions globally, providing robust assistance in the prevention and control of livestock husbandry epidemics. In the future, Tianlong will continuously strive to engage in research and development to contribute its scientific and technological expertise. About Tianlong Tianlong is an innovative high-tech company specializing in molecular diagnostic products in China. Since its foundation in 1997, Tianlong has devoted itself to providing integrated PCR lab solutions for professionals worldwide. We have a wide range of products covering from devices to reagents, including nucleic acid extractors, Real-time PCR systems, All-in-one molecular diagnosis systems, sample processing systems, liquid handling systems, and 300 kinds of compatible reagents. With NMPA, CE, and FDA listing, our products have been exported to more than 100 countries and regions worldwide and have greatly helped the prevention and control of epidemics such as COVID-19, SARS, Avian influenza, Ebola, Zika, and African swine fever. For more information, please visit Tianlong's official website and its LinkedIn, Facebook, and Twitter pages. For product or corporate information inquiries may be directed to [email protected]. Media Contact: Kaylee Zhang [email protected] +86-15991940095 SOURCE Xi'an TianLong Science and Technology Co., Ltd

NEW YORK, July 1, 2022 /PRNewswire/ -- The "Animal Disinfectant Market by Type (liquid animal disinfectant and powdered animal disinfectant) and Geography (Europe, North America, Asia, and ROW) - Forecast and Analysis 2021-2025" report has been added to Technavio's offering. With ISO 9001:2015 certification, Technavio is proudly partnering with more than 100 Fortune 500 companies for over 16 years. The animal disinfectant market size is expected to increase by USD 1.17 million from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 6.75%. 42% of the market's growth will originate from Asia during the forecast period. China is the key market for the animal disinfectant market in Asia. Market growth in this region will be faster than the growth of the market in regions. The increasing prevalence of infectious diseases in animals will facilitate the animal disinfectant market growth in Asia over the forecast period Technavio has announced its latest market research report titled Animal Disinfectant Market by Type and Geography - Forecast and Analysis 2021-2025 Animal Disinfectant Market: Segmentation Analysis The animal disinfectant market report is segmented by Type (liquid animal disinfectant and powdered animal disinfectant) and Geography (Europe, North America, Asia, and ROW). Revenue generating segment: The animal disinfectant market share growth in the Liquid animal disinfectant segment will be significant for revenue generation. Liquid animal disinfectants are offered with the premixed dilution of concentrates (active ingredients) in the solvent (usually water). These products have higher adoption among end-users owing to their wide range of applications, including foot dips, footbaths, aerial disinfection, foam-based sprays, and water-system disinfection. For additional insights into the contribution of all the segments - Grab a sample report Animal Disinfectant Market: Key Market Dynamics Major Driver: An increasing prevalence of infectious diseases in animals is one of the key factors driving the growth of the global animal disinfectant market. The increasing prevalence of infectious diseases such as avian influenza, African swine fever, brucellosis, East Coast fever, African animal trypanosomiasis, Newcastle disease, porcine reproductive and respiratory syndrome (PRRS), and FMD has become a major concern among livestock farmers and governments across the globe. These diseases severely impact the livestock population by spreading like an epidemic with a high mortality rate. Moreover, a significant number of human diseases are zoonotic in origin and spread due to the direct or indirect contact of humans with the saliva, urine, blood, feces, mucous, or other body fluids of an infected animal. Advanced disinfectants have broad germicidal capabilities to remove such pathogens. Thus, to prevent infectious outbreaks, cleaning and disinfection processes using animal disinfectant products are gaining widespread adoption among animal care and animal breeding premises, which is driving the growth of the global animal disinfectant market Major Challenges: The stringent registration procedure is a major challenge for the global animal disinfectant market growth. Vendors manufacturing animal disinfectants operate in a highly regulated environment. A significant share of capital is invested by vendors in product R&D. However, as animal disinfectants involve the use of toxic chemicals, new formulations are subjected to strict testing trials and registration procedures for ensuring their safety. Failure in the performance and optimum safety standards may expose the products to the risk of rejection and discontinuation, thus causing significant financial loss to vendors. Furthermore, FIFRA mandates the disclosure and labeling of proper directions and safety precautions on the product. In addition to federal regulations, the US also has the presence of individual state-defined regulations. However, the disinfectant products that comply with these regulations can be commercialized in the EU countries. Similarly, in China, disinfectants are required to comply with the requirements of the Chinese Disinfectant Regulation. Vendors operating internationally often find it difficult to comply with the stringent and varying regulations across regions, which hampers their operational efficiencies and refrains the growth of the global animal disinfectant market. For additional details on the key drivers, trends, and challenges -. Request a Sample Report right now! Animal Disinfectant Market: Vendor Analysis The animal disinfectant market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market. CID LINES NV Diversey Inc. Evans Vanodine International Plc GEA Group Aktiengesellschaft KERSIA GROUP LANXESS AG Neogen Corp. Sanosil Ltd. Virox Technologies Inc. Zoetis Inc. To gain access to more vendor profiles with their key offerings available with Technavio, Click Here Get ready to achieve excellent business outcomes from this exclusive Animal Disinfectant Market report by Technavio. The report will include highlights of the overall market which includes frequently asked questions such as - What are historical revenue figures and estimated revenue figures as well as CAGR during the forecast timeframe? What is the current trend taking place in the market space? Which are business tactics that will influence competitive scenarios along with defining the growth potential of the market? What are market drivers, restraints, and challenges impacting demand & growth of the market? Which regions & segments will garner massive revenue and emerge as market leaders in upcoming years? The competitive scenario provided in the Animal Disinfectant Market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.Don't wait, Make a strategic approach & boost your business goals with our Animal Disinfectant Market Forecast Report - Buy Now! Related Reports: The animal healthcare market share is expected to increase by USD 7.98 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 4.1%. The vaccine research market share is expected to increase to USD 13.34 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 8.36% Key Topics Covered: 1 Executive Summary 2 Market Landscape 2.1 Market ecosystem Exhibit 01: Parent market Exhibit 02: Market characteristics 2.2 Value chain analysis Exhibit 03: Value chain analysis: Life sciences tools and services 3 Market Sizing 3.1 Market definition Exhibit 04: Offerings of vendors included in the market definition 3.2 Market segment analysis Exhibit 05: Market segments 3.3 Market size 2020 3.4 Market outlook: Forecast for 2020 - 2025 Exhibit 06: Global - Market size and forecast 2020 - 2025 ($ million) Exhibit 07: Global market: Year-over-year growth 2020 - 2025 (%) 4 Five Forces Analysis 4.1 Five forces summary Exhibit 08: Five forces analysis 2020 & 2025 4.2 Bargaining power of buyers Exhibit 09: Bargaining power of buyers 4.3 Bargaining power of suppliers Exhibit 10: Bargaining power of suppliers 4.4 Threat of new entrants Exhibit 11: Threat of new entrants 4.5 Threat of substitutes Exhibit 12: Threat of substitutes 4.6 Threat of rivalry Exhibit 13: Threat of rivalry 4.7 Market condition Exhibit 14: Market condition - Five forces 2020 5 Market Segmentation by Type 5.1 Market segments Exhibit 15: Type - Market share 2020-2025 (%) 5.2 Comparison by Type Exhibit 16: Comparison by Type 5.3 Liquid animal disinfectant - Market size and forecast 2020-2025 Exhibit 17: Liquid animal disinfectant - Market size and forecast 2020-2025 ($ million) Exhibit 18: Liquid animal disinfectant - Year-over-year growth 2020-2025 (%) 5.4 Powdered animal disinfectant - Market size and forecast 2020-2025 Exhibit 19: Powdered animal disinfectant - Market size and forecast 2020-2025 ($ million) Exhibit 20: Powdered animal disinfectant - Year-over-year growth 2020-2025 (%) 5.5 Market opportunity by Type Exhibit 21: Market opportunity by Type 6 Customer landscape 7 Geographic Landscape 7.1 Geographic segmentation Exhibit 23: Market share by geography 2020-2025 (%) 7.2 Geographic comparison Exhibit 24: Geographic comparison 7.3 Europe - Market size and forecast 2020-2025 Exhibit 25: Europe - Market size and forecast 2020-2025 ($ million) Exhibit 26: Europe - Year-over-year growth 2020-2025 (%) 7.4 North America - Market size and forecast 2020-2025 Exhibit 27: North America - Market size and forecast 2020-2025 ($ million) Exhibit 28: North America - Year-over-year growth 2020-2025 (%) 7.5 Asia - Market size and forecast 2020-2025 Exhibit 29: Asia - Market size and forecast 2020-2025 ($ million) Exhibit 30: Asia - Year-over-year growth 2020-2025 (%) 7.6 ROW - Market size and forecast 2020-2025 Exhibit 31: ROW - Market size and forecast 2020-2025 ($ million) Exhibit 32: ROW - Year-over-year growth 2020-2025 (%) 7.7 Key leading countries Exhibit 33: Key leading countries 7.8 Market opportunity by geography Exhibit 34: Market opportunity by geography ($ million) 8 Drivers, Challenges, and Trends 8.1 Market drivers 8.2 Market challenges Exhibit 35: Impact of drivers and challenges 8.3 Market trends 9 Vendor Landscape 9.1 Overview 9.2 Vendor landscape Exhibit 36: Vendor landscape 9.3 Landscape disruption Exhibit 37: Landscape disruption Exhibit 38: Industry risks 10 Vendor Analysis 10.1 Vendors covered Exhibit 39: Vendors covered 10.2 Market positioning of vendors Exhibit 40: Market positioning of vendors 10.3 CID LINES NV Exhibit 41: CID LINES NV - Overview Exhibit 42: CID LINES NV - Product and service Exhibit 43: CID LINES NV - Key offerings 10.4 Diversey Inc. Exhibit 44: Diversey Inc. - Overview Exhibit 45: Diversey Inc. - Product and service Exhibit 46: Diversey Inc. - Key offerings 10.5 Evans Vanodine International Plc 10.6 GEA Group Aktiengesellschaft Exhibit 51: GEA Group Aktiengesellschaft - Overview Exhibit 52: GEA Group Aktiengesellschaft - Business segments Exhibit 53: GEA Group Aktiengesellschaft - Key news Exhibit 54: GEA Group Aktiengesellschaft - Key offerings Exhibit 55: GEA Group Aktiengesellschaft - Segment focus 10.7 KERSIA GROUP Exhibit 56: KERSIA GROUP - Overview Exhibit 57: KERSIA GROUP - Product and service Exhibit 58: KERSIA GROUP - Key news Exhibit 59: KERSIA GROUP - Key offerings 10.8 LANXESS AG Exhibit 60: LANXESS AG - Overview Exhibit 61: LANXESS AG - Business segments Exhibit 62: LANXESS AG - Key news Exhibit 63: LANXESS AG - Key offerings Exhibit 64: LANXESS AG - Segment focus 10.9 Neogen Corp. Exhibit 65: Neogen Corp. - Overview Exhibit 66: Neogen Corp. - Business segments Exhibit 67: Neogen Corp. - Key news Exhibit 68: Neogen Corp. - Key offerings Exhibit 69: Neogen Corp. - Segment focus 10.10 Sanosil Ltd. Exhibit 70: Sanosil Ltd. - Overview Exhibit 71: Sanosil Ltd. - Product and service Exhibit 72: Sanosil Ltd. - Key offerings 10.11 Virox Technologies Inc. Exhibit 73: Virox Technologies Inc. - Overview Exhibit 74: Virox Technologies Inc. - Product and service Exhibit 75: Virox Technologies Inc. - Key news Exhibit 76: Virox Technologies Inc. - Key offerings 10.12 Zoetis Inc. Exhibit 77: Zoetis Inc. - Overview Exhibit 78: Zoetis Inc. - Business segments Exhibit 79: Zoetis Inc. - Key news Exhibit 80: Zoetis Inc. - Key offerings Exhibit 81: Zoetis Inc. - Segment focus 11 Appendix 11.1 Scope of the report 11.2 Currency conversion rates for US$ Exhibit 82: Currency conversion rates for US$ 11.3 Research methodology Exhibit 83: Research Methodology Exhibit 84: Validation techniques employed for market sizing Exhibit 85: Information sources 11.4 List of abbreviations Exhibit 86: List of abbreviations About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email:[email protected] Website: SOURCE Technavio

Researchers have developed a new form of rapid test to detect infections in farm animals, responding to the rising threat of dangerous outbreaks. Researchers at McMaster University have developed a new form of rapid test to detect infections in farm animals, responding to the rising threat of dangerous outbreaks. The prototype has been proven effective in detecting a devastating diarrheal infection in pigs first identified in Canada in 2014, and can be adapted to test for other pathogens, and in other animals. The test, created by biochemist Yingfu Li and engineer Leyla Soleymani and their colleagues, uses a small sample of saliva to detect the chemical markers of infection. It employs technology similar to a form of test the same research team recently created to detect COVID and other infections in humans. The human test is now moving toward the marketplace with public research funding and corporate support. The animal test, once it becomes widely available, is expected to be a valuable tool for identifying and isolating outbreaks in farm settings, and for limiting the possibility of animal-to-human transmission of infections, which is believed to be the origin of the COVID-19 pandemic. Disease outbreaks often require entire herds to be euthanized, with sometimes severe economic and environmental consequences. Canada is a leading producer of pork, with 14 million hogs on 7,600 farms. "There is a really a clear need for this technology," Li said. "There are many reasons why everyone -- even people who don't eat pork -- should care about animal-infection surveillance." The work has been published today in the influential German science journal Angewandte Chemie, which has identified it as a "very important paper" -- a specific and rare distinction. The research was funded by the Natural Sciences and Engineering Research Council of Canada. Li and Soleymani's co-authors on the paper are Amanda Victorious,Zijie Zhang,Dingran Chang,Roderick Maclachlan, Richa Pandey,Jianrun Xia,Jimmy Gu and Todd Hoare. The new test could be a significant advancement in the concept of "One Health," the growing understanding of the interconnection between human, animal and ecosystem health. Creating such technology is part of the mission of McMaster's broader Global Nexus for Pandemics and Biological Threats. The researchers have designed the aptamer-based test to be portable, accurate and quick, allowing veterinarians and other animal caretakers to identify, isolate and treat infected animals quickly. The test works by mixing a small saliva sample with a chemical reagent and applying the blend to a small microchip reader, which is in turn attached to a smartphone, which displays the results in minutes. After consulting with experts in the field, the researchers chose to create their first animal test for Porcine Epidemic Diarhhea, a serious viral threat which can spread quickly through entire farms. One of the greatest technical challenges in developing the test over the last four years was to extract the infection's chemical signature from the thick and often contaminated saliva of pigs, using samples collected by veterinarian collaborators. "The challenge here was that the samples we get from animal swabs are much less pure than what we get from humans," Soleymani said. "You can't tell a pig to rinse its mouth before swabbing it, so we had to adapt our process to accommodate these challenges."